268 related articles for article (PubMed ID: 33036956)
1. Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.
Dey L; Chakraborty S; Mukhopadhyay A
Biomed J; 2020 Oct; 43(5):438-450. PubMed ID: 33036956
[TBL] [Abstract][Full Text] [Related]
2. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
Nadeau R; Shahryari Fard S; Scheer A; Hashimoto-Roth E; Nygard D; Abramchuk I; Chung YE; Bennett SAL; Lavallée-Adam M
J Proteome Res; 2020 Nov; 19(11):4553-4566. PubMed ID: 33103435
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
Ong E; Wong MU; Huffman A; He Y
Front Immunol; 2020; 11():1581. PubMed ID: 32719684
[TBL] [Abstract][Full Text] [Related]
4. Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods.
Kivrak M; Guldogan E; Colak C
Comput Methods Programs Biomed; 2021 Apr; 201():105951. PubMed ID: 33513487
[TBL] [Abstract][Full Text] [Related]
5. Determining human-coronavirus protein-protein interaction using machine intelligence.
Chakraborty A; Mitra S; Bhattacharjee M; De D; Pal AJ
Med Nov Technol Devices; 2023 Jun; 18():100228. PubMed ID: 37056696
[TBL] [Abstract][Full Text] [Related]
6. A new hybrid ensemble machine-learning model for severity risk assessment and post-COVID prediction system.
Shakhovska N; Yakovyna V; Chopyak V
Math Biosci Eng; 2022 Apr; 19(6):6102-6123. PubMed ID: 35603393
[TBL] [Abstract][Full Text] [Related]
7. Transfer learning-based ensemble support vector machine model for automated COVID-19 detection using lung computerized tomography scan data.
Singh M; Bansal S; Ahuja S; Dubey RK; Panigrahi BK; Dey N
Med Biol Eng Comput; 2021 Apr; 59(4):825-839. PubMed ID: 33738639
[TBL] [Abstract][Full Text] [Related]
8. Prediction of interactions between viral and host proteins using supervised machine learning methods.
Barman RK; Saha S; Das S
PLoS One; 2014; 9(11):e112034. PubMed ID: 25375323
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
10. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.
Albahri AS; Hamid RA; Alwan JK; Al-Qays ZT; Zaidan AA; Zaidan BB; Albahri AOS; AlAmoodi AH; Khlaf JM; Almahdi EM; Thabet E; Hadi SM; Mohammed KI; Alsalem MA; Al-Obaidi JR; Madhloom HT
J Med Syst; 2020 May; 44(7):122. PubMed ID: 32451808
[TBL] [Abstract][Full Text] [Related]
11. Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.
Miczi M; Golda M; Kunkli B; Nagy T; Tőzsér J; Mótyán JA
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333742
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
[TBL] [Abstract][Full Text] [Related]
13. Protein sequence models for prediction and comparative analysis of the SARS-CoV-2 -human interactome.
Kshirsagar M; Tasnina N; Ward MD; Law JN; Murali TM; Lavista Ferres JM; Bowman GR; Klein-Seetharaman J
Pac Symp Biocomput; 2021; 26():154-165. PubMed ID: 33691013
[TBL] [Abstract][Full Text] [Related]
14. A robust protein language model for SARS-CoV-2 protein-protein interaction network prediction.
Ozger ZB
Artif Intell Med; 2023 Aug; 142():102574. PubMed ID: 37316102
[TBL] [Abstract][Full Text] [Related]
15. SMMPPI: a machine learning-based approach for prediction of modulators of protein-protein interactions and its application for identification of novel inhibitors for RBD:hACE2 interactions in SARS-CoV-2.
Gupta P; Mohanty D
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839740
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
[TBL] [Abstract][Full Text] [Related]
17. Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population.
Banerjee A; Ray S; Vorselaars B; Kitson J; Mamalakis M; Weeks S; Baker M; Mackenzie LS
Int Immunopharmacol; 2020 Sep; 86():106705. PubMed ID: 32652499
[TBL] [Abstract][Full Text] [Related]
18. The viral protein fragment theory of COVID-19 pathogenesis.
Suzuki YJ
Med Hypotheses; 2020 Nov; 144():110267. PubMed ID: 33254571
[TBL] [Abstract][Full Text] [Related]
19. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.
Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W
Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008
[TBL] [Abstract][Full Text] [Related]
20. In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species.
Delgado Blanco J; Hernandez-Alias X; Cianferoni D; Serrano L
PLoS Comput Biol; 2020 Dec; 16(12):e1008450. PubMed ID: 33284795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
